SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/28/24 BRP Inc. 40-F 1/31/24 167:23M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: 40-F Annual Report by a Canadian Issuer HTML 470K 8: EX-23.1 Consent of Expert or Counsel HTML 43K 2: EX-97 Clawback Policy re: Recovery of Erroneously HTML 65K Awarded Compensation 3: EX-99.1 Miscellaneous Exhibit HTML 503K 4: EX-99.2 Miscellaneous Exhibit HTML 3.29M 5: EX-99.3 Miscellaneous Exhibit HTML 995K 6: EX-99.4 Miscellaneous Exhibit HTML 116K 7: EX-99.5 Miscellaneous Exhibit HTML 117K 9: EX-31.1 Certification -- §302 - SOA'02 HTML 49K 10: EX-31.2 Certification -- §302 - SOA'02 HTML 49K 11: EX-32.1 Certification -- §906 - SOA'02 HTML 45K 12: EX-32.2 Certification -- §906 - SOA'02 HTML 44K 18: R1 Cover Page HTML 112K 19: R2 Consolidated Statements of Net Income HTML 98K 20: R3 Consolidated Statements of Comprehensive Income HTML 84K 21: R4 Consolidated Statements of Financial Position HTML 133K 22: R5 Consolidated Statements of Changes in Equity HTML 82K 23: R6 Consolidated Statements of Changes in Equity HTML 46K (Parenthetical) 24: R7 Consolidated Statements of Cash Flows HTML 136K 25: R8 Nature of Operations HTML 49K 26: R9 Significant Accounting Policies HTML 121K 27: R10 Significant Estimates And Judgments HTML 69K 28: R11 Future Accounting Changes HTML 52K 29: R12 Business Combinations HTML 117K 30: R13 Trade and Other Receivables HTML 65K 31: R14 Other Financial Assets HTML 70K 32: R15 Inventories HTML 62K 33: R16 Other Assets HTML 65K 34: R17 Property, Plant and Equipment HTML 149K 35: R18 Intangible Assets HTML 173K 36: R19 Leases HTML 102K 37: R20 Revolving Credit Facilities HTML 58K 38: R21 Trade Payables and Accruals HTML 64K 39: R22 Provisions HTML 90K 40: R23 Other Financial Liabilities HTML 72K 41: R24 Long-Term Debt HTML 157K 42: R25 Employee Benefits HTML 201K 43: R26 Capital Stock HTML 82K 44: R27 Stock Option Plan HTML 184K 45: R28 Segmented Information HTML 175K 46: R29 Earnings Per Share HTML 70K 47: R30 Revenues HTML 56K 48: R31 Cost of sales HTML 48K 49: R32 Government assistance HTML 56K 50: R33 Impairment Charge HTML 49K 51: R34 Other Operating Expenses (Income) HTML 55K 52: R35 Financing Costs And Income HTML 68K 53: R36 Income Taxes HTML 146K 54: R37 Related Party Transactions HTML 60K 55: R38 Financial Instruments HTML 533K 56: R39 Capital Management HTML 48K 57: R40 Commitments and Contingencies HTML 68K 58: R41 Significant Accounting Policies (Policies) HTML 156K 59: R42 Significant Accounting Policies (Tables) HTML 52K 60: R43 Business Combinations (Tables) HTML 117K 61: R44 Trade and Other Receivables (Tables) HTML 64K 62: R45 Other Financial Assets (Tables) HTML 69K 63: R46 Inventories (Tables) HTML 61K 64: R47 Other Assets (Tables) HTML 64K 65: R48 Property, Plant and Equipment (Tables) HTML 150K 66: R49 Intangible Assets (Tables) HTML 175K 67: R50 Leases (Tables) HTML 103K 68: R51 Trade Payables and Accruals (Tables) HTML 64K 69: R52 Provisions (Tables) HTML 90K 70: R53 Other Financial Liabilities (Tables) HTML 71K 71: R54 Long-Term Debt (Tables) HTML 145K 72: R55 Employee Benefits (Tables) HTML 199K 73: R56 Capital Stock (Tables) HTML 67K 74: R57 Stock Option Plan (Tables) HTML 140K 75: R58 Segmented Information (Tables) HTML 176K 76: R59 Earnings Per Share (Tables) HTML 69K 77: R60 Revenues (Tables) HTML 55K 78: R61 Government assistance (Tables) HTML 55K 79: R62 Other Operating Expenses (Income) (Tables) HTML 54K 80: R63 Financing Costs And Income (Tables) HTML 67K 81: R64 Income Taxes (Tables) HTML 142K 82: R65 Related Party Transactions (Tables) HTML 57K 83: R66 Financial Instruments (Tables) HTML 528K 84: R67 Commitments and Contingencies (Tables) HTML 57K 85: R68 Significant Accounting Policies - Additional HTML 60K Information (Detail) 86: R69 Significant Accounting Policies - Summary of HTML 58K Estimated Useful Lives of Property Plant and Equipment (Detail) 87: R70 Significant Accounting Policies - Summary of HTML 60K Estimated Useful Lives Intangible Assets (Detail) 88: R71 Significant Estimates And Judgments - Additional HTML 97K Information (Detail) 89: R72 Business Combinations - Additional Information HTML 53K (Detail) 90: R73 Business Combinations - Summary of Value of the HTML 89K Assets Acquired and Liabilities Assumed (Detail) 91: R74 Business Combinations - Summary of Value of the HTML 48K Assets Acquired and Liabilities Assumed (Parenthetical) (Detail) 92: R75 Trade and Other Receivables - Summary on Trade and HTML 56K Other Receivables (Detail) 93: R76 Other Financial Assets - Summary of Other HTML 59K Financial Assets (Detail) 94: R77 Inventories - Summary of Inventories (Detail) HTML 53K 95: R78 Inventories - Additional Information (Detail) HTML 53K 96: R79 Other Assets - Summary of Other Assets (Detail) HTML 56K 97: R80 Property, Plant and Equipment - Schedule of HTML 71K Company's Property, Plant and Equipment (Detail) 98: R81 Property, Plant and Equipment - Additional HTML 47K Information (Detail) 99: R82 Property, Plant and Equipment - Schedule of HTML 80K Changes in Property, Plant and Equipment (Detail) 100: R83 Property, Plant and Equipment - Schedule of HTML 51K Changes in Property, Plant and Equipment (Parenthetical) (Detail) 101: R84 Intangible Assets - Summary of Intangible Assets HTML 80K (Detail) 102: R85 Intangible Assets - Summary of Changes in HTML 85K Company's Intangible Assets (Detail) 103: R86 Intangible Assets - Summary of Changes in HTML 52K Company's Intangible Assets (Parenthetical) (Detail) 104: R87 Leases - Summary of changes in right of use assets HTML 66K (Detail) 105: R88 Leases - Summary of changes in right of use assets HTML 51K (Parenthetical) (Detail) 106: R89 Leases - Summary of changes in lease liabilities HTML 59K (Detail) 107: R90 Leases - Summary of changes in lease liabilities HTML 50K (Parenthetical) (Detail) 108: R91 Revolving Credit Facilities - Additional HTML 100K Information (Detail) 109: R92 Trade Payables and Accruals - Summary of Trade HTML 53K Payables and Accruals (Detail) 110: R93 Provisions - Summary of Provisions (Detail) HTML 54K 111: R94 Provisions - Summary of Changes in Provisions HTML 65K (Detail) 112: R95 Other Financial Liabilities - Summary of Other HTML 60K Financial Liabilities (Detail) 113: R96 Long-Term Debt - Summary of Longterm Debt (Detail) HTML 82K 114: R97 Long-Term Debt - Summary of Longterm Debt HTML 53K (Parenthetical) (Detail) 115: R98 Long-Term Debt - Summary of Changes in Longterm HTML 64K Debt (Detail) 116: R99 Long-Term Debt - Additional Information (Detail) HTML 130K 117: R100 Employee Benefits - Summary of Employee Benefits HTML 61K Expenses (Detail) 118: R101 Employee Benefits - Summary of Employee Benefits HTML 49K Expenses (Parenthetical) (Detail) 119: R102 Employee Benefits - Additional Information HTML 64K (Detail) 120: R103 Employee Benefits - Weighted average of HTML 63K significant actuarial assumptions adopted to determine defined benefit cost and defined benefit obligation (Detail) 121: R104 Employee Benefits - Summary of company's HTML 64K obligations under defined benefit obligations (Detail) 122: R105 Employee Benefits - Reconciliation of the changes HTML 75K in the pension plans defined benefit obligations (Detail) 123: R106 Employee Benefits - Reconciliation of the changes HTML 66K in the pension plans fair value of assets (Detail) 124: R107 Employee Benefits - Schedule of Actual Return HTML 51K (loss) on Plan Assets (Detail) 125: R108 Employee Benefits - Summary of Fair Value of Plan HTML 60K Assets (Detail) 126: R109 Employee Benefits - Summary of Fair Value of Plan HTML 47K Assets (Parenthetical) (Detail) 127: R110 Employee Benefits - Components of the Total HTML 60K Defined Benefit Costs (Detail) 128: R111 Employee Benefits - Summary of Sensitivity HTML 57K Analysis of Impact on Employee Future Benefit Liabilities (Detail) 129: R112 Capital Stock - Summary of Changes in Capital HTML 73K Stock Issued and Outstanding (Detail) 130: R113 Capital Stock - Summary of Changes in Capital HTML 50K Stock Issued and Outstanding (Parenthetical) (Detail) 131: R114 Capital Stock - Additional Information (Detail) HTML 106K 132: R115 Stock Option Plan - Additional Information HTML 62K (Detail) 133: R116 Stock Option Plan - Summary of Weighted-Average HTML 58K Fair Value of Options Granted (Detail) 134: R117 Stock Option Plan - Summary of Stock Option HTML 69K (Detail) 135: R118 Stock Option Plan - Summary of Stock Option HTML 47K (Parenthetical) (Detail) 136: R119 Stock Option Plan - Summary of Stock Options HTML 115K Outstanding and Exercisable (Detail) 137: R120 Segmented Information - Summary of Segment HTML 85K Information (Detail) 138: R121 Segmented Information - Summary of Segment HTML 49K Information (Parenthetical) (Detail) 139: R122 Segmented Information - Summary of Geographical HTML 69K Information on Company's Revenues, Property,Plant and Equipment and Intangible Assets (Detail) 140: R123 Earnings Per Share - Summary of Basic Earnings Per HTML 51K Share (Detail) 141: R124 Earnings Per Share - Summary of Diluted Earnings HTML 56K Per Share (Detail) 142: R125 Revenues - Summary of revenues (Detail) HTML 58K 143: R126 Cost Of Sales - Additional Information (Detail) HTML 46K 144: R127 Government assistance - Schedule of Company's HTML 57K Government Assistance, Including Tax Credits (Detail) 145: R128 Impairment Charge - Additional Information HTML 61K (Detail) 146: R129 Other Operating Expenses (Income) - Summary of HTML 52K Other Operating Expenses (Income) (Detail) 147: R130 Financing Costs And Income - Schedule of Financing HTML 61K Costs and Financing Income (Detail) 148: R131 Income Taxes - Summary of Income Tax Expense HTML 65K (Detail) 149: R132 Income Taxes - Schedule of Reconciliation of HTML 70K Income Taxes Computed at Canadian Statutory Rates to Income Tax Expense (Detail) 150: R133 Income Taxes - Additional Information (Detail) HTML 60K 151: R134 Income Taxes - Components of Deferred Income Taxes HTML 91K Asset (Liability) (Detail) 152: R135 Related Party Transactions - Summary of Benefit HTML 53K Expenses in Relation with Key Management Personnel (Detail) 153: R136 Related Party Transactions - Additional HTML 48K Information (Detail) 154: R137 Financial Instruments - Summary of Fair Value, HTML 90K Fair Value Level and Valuations Techniques and Inputs of Restricted Investments, Derivative Financial Instruments and Long-term Debt (Detail) 155: R138 Financial Instruments - Summary of Impact on HTML 57K Consolidated Net Income and Other Comprehensive Income of Variation of Foreign Exchange Rates on Financial Instruments Subject to Foreign Exchange Risks (Detail) 156: R139 Financial Instruments - Additional Information HTML 56K (Detail) 157: R140 Financial Instruments - Summary of Notional HTML 412K Amounts Outstanding Under Foreign Exchange Contracts, Average Contractual Exchange Rates and Settlement Periods of Contracts (Detail) 158: R141 Financial Instruments - Summary of Financial HTML 75K Liabilities Instalments Payable When Contractually Due (Detail) 159: R142 Financial Instruments - Summary of Information HTML 66K Considered to be Exposed to Credit Risk (Detail) 160: R143 Capital Management - Additional Information HTML 47K (Detail) 161: R144 Commitments and Contingencies - Additional HTML 58K Information (Detail) 162: R145 Commitments and Contingencies - Summary of HTML 60K Breakdown of Outstanding Amounts by Country and Local Currency between Independent Dealers and Distributors with Third Party Finance Companies (Detail) 164: XML IDEA XML File -- Filing Summary XML 312K 167: XML XBRL Instance -- d643236d40f_htm XML 6.64M 163: EXCEL IDEA Workbook of Financial Report Info XLSX 314K 14: EX-101.CAL XBRL Calculations -- dooo-20240131_cal XML 223K 15: EX-101.DEF XBRL Definitions -- dooo-20240131_def XML 1.25M 16: EX-101.LAB XBRL Labels -- dooo-20240131_lab XML 2.28M 17: EX-101.PRE XBRL Presentations -- dooo-20240131_pre XML 1.79M 13: EX-101.SCH XBRL Schema -- dooo-20240131 XSD 511K 165: JSON XBRL Instance as JSON Data -- MetaLinks 624± 960K 166: ZIP XBRL Zipped Folder -- 0001193125-24-079609-xbrl Zip 763K
40-F |
REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 |
ANNUAL REPORT PURSUANT TO SECTION 13(a) OR |
15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the fiscal year ended i i January 31, i 2024 / |
Commission File Number: |
Title of each class | Trading Symbol(s) |
Name of each exchange on which registered | ||
i Subordinate Voting Shares |
i DOOO |
i The Nasdaq Stock Market LLC |
Auditor Firm Id: i 1208 | Auditor Name: i Deloitte LLP | Auditor Location: i Montreal, Canada |
PRINCIPAL DOCUMENTS
The following documents have been filed as part of this Annual Report on Form 40-F:
A. Annual Information Form
The Registrant’s Annual Information Form for the year ended January 31, 2024 is attached as Exhibit 99.1 to this Annual Report on Form 40-F and is incorporated by reference herein.
B. Audited Annual Financial Statements
The Registrant’s audited annual consolidated financial statements for the year ended January 31, 2024, including the reports of the independent registered public accounting firm with respect thereto, are attached as Exhibit 99.2 to this Annual Report on Form 40-F and are incorporated by reference herein.
C. Management’s Discussion and Analysis
The Registrant’s Management’s Discussion and Analysis for the year ended January 31, 2024 is attached as Exhibit 99.3 to this Annual Report on Form 40-F and is incorporated by reference herein.
CONTROLS AND PROCEDURES
The Company’s President and Chief Executive Officer and the Chief Financial Officer are responsible for establishing and maintaining the Company’s disclosure controls and procedures as well as its internal control over financial reporting, as those terms are defined in National Instrument 52-109 – Certification of Disclosure in Issuers’ Annual and Interim Filings of the Canadian securities regulatory authorities, Rule 13a-15(e) and Rule 15d-15(e) under the U.S. Securities Exchange Act of 1934, as amended (the “Exchange Act”) and Rule 13a-15(f) and Rule 15d-15(f) under the Exchange Act.
Disclosure controls and procedures
The President and Chief Executive Officer and the Chief Financial Officer have designed, or caused to be designed under their supervision, disclosure controls and procedures in order to provide reasonable assurance that:
• | material information relating to the Company has been made known to them; and |
• | information required to be disclosed in the Company’s filings is recorded, processed, summarized and reported within the time periods specified in securities legislation. |
An evaluation of the design and effectiveness of the Company’s disclosure controls and procedures was carried out under the supervision of the President and Chief Executive Officer and the Chief Financial Officer. Based on this evaluation, the President and Chief Executive Officer and the Chief Financial Officer concluded, as of January 31, 2024, that the Company’s disclosure controls and procedures were effective.
Management’s Report on Internal Control over Financial Reporting
The President and Chief Executive Officer and the Chief Financial Officer have designed, or caused to be designed under their supervision, such internal control over financial reporting to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board.
Due to its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Management’s projections of any evaluation of the effectiveness of internal control over financial reporting as to future periods are subject to the risks that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis.
An evaluation of the design and effectiveness of the Company’s internal controls over financial reporting was carried out under the supervision of the President and Chief Executive Officer and the Chief Financial Officer. In making this evaluation, the President and Chief Executive Officer and the Chief Financial Officer used the criteria set forth by the Committee of Sponsoring
Organizations of the Treadway Commission Internal Control – Integrated Framework (2013). Based on this evaluation, the President and Chief Executive Officer and the Chief Financial Officer concluded, as of January 31, 2024, that the Company’s internal controls over financial reporting were effective.
Our internal control over financial reporting as of January 31, 2024 has been audited by Deloitte LLP, independent registered public accounting firm, who also audited our consolidated financial statements for the year ended January 31, 2024. Deloitte LLP issued an unqualified opinion, as stated in their report, on the effectiveness of our internal control over financial reporting as of January 31, 2024.
Changes in internal control over financial reporting
There were no changes in the Company’s internal control over financial reporting during the three- and twelve-month periods ended January 31, 2024, that have materially affected, or are reasonably likely to materially affect the Company’s internal control over financial reporting.
Attestation report of registered public accounting firm
The attestation report of Deloitte LLP on management’s internal control over financial reporting is filed in Exhibit 99.2 to this Annual Report on Form 40-F, and is incorporated herein by reference.
NOTICES PURSUANT TO REGULATION BTR
There were no notices required by Rule 104 of Regulation BTR that the Registrant sent during the year ended January 31, 2024 concerning any equity security subject to a blackout period under Rule 101 of Regulation BTR.
AUDIT COMMITTEE FINANCIAL EXPERT
The Registrant’s board of directors (the “Board of Directors”) has determined that it has at least one audit committee financial expert (as such term is defined in item 8(a) of General Instruction B to Form 40-F) serving on its audit committee (the “Audit Committee”). Michael Ross has been determined by the Board of Directors to be such audit committee financial expert and is independent (as such term is defined by the Nasdaq Stock Market’s corporate governance standards applicable to the Registrant).
Mr. Ross is a corporate director. He was Chief Financial Officer of Sesami Cash Management Technologies Corporation (“Sesami”) from 2022 to 2023. In this role, he was responsible for all financial activities, corporate development, and strategic planning. Prior to joining Sesami, Mr. Ross was Chief Financial Officer of Dollarama Inc. for over a decade. Prior to that, Mr. Ross was CFO of Sanimax Industries, a rendering services company, and spent over 20 years in senior financial roles in the television and broadcasting industry. He began his career as an auditor with Ernst & Young. Mr. Ross is a member of the board of directors of Pixcom Inc., the Fondation CHU Saint Justine and FEI – Quebec Chapter. He was previously a member of the board of directors of Investissement Québec, la Fondation Marie-Vincent, Fondation Dr Clown and Muscular Dystrophy Canada. Mr. Ross holds a bachelor’s degree in commerce and a graduate diploma in accounting from Concordia University. He received the Fellow of the Order distinction (FCPA) in 2012.
The SEC has indicated that the designation of Michael Ross as an audit committee financial expert does not make him an “expert” for any purpose, impose on him any duties, obligations or liability that are greater than the duties, obligations or liability imposed on him as a member of the Audit Committee and the Board of Directors in absence of such designation, or affect the duties, obligations or liability of any other member of the Audit Committee or Board of Directors.
CODE OF ETHICS
The Registrant has adopted a Code of Ethics that applies to all directors, officers and employees of the Registrant and its subsidiaries (collectively, “covered persons”). A copy of the Code of Ethics can be obtained, free of charge, on the Registrant’s website (www.brp.com) or by contacting the Registrant at (450) 532-6154.
PRINCIPAL ACCOUNTANT FEES AND SERVICES
The following table sets out the fees billed to the Registrant by Deloitte LLP for professional services rendered for the fiscal period ended January 31, 2024 and January 31, 2023. During this period, Deloitte LLP was the Registrant’s only external auditor.
(in Canadian dollars) | Year ended January 31, 2024 |
Year ended January 31, 2023 |
||||||
Audit Fees(1) |
$ | 5,515,701 | $ | 4,541,500 | ||||
Audit-Related Fees(2) |
1,165,189 | 772,597 | ||||||
Tax Fees(3) |
124,674 | 126,429 | ||||||
All Other Fees(4) |
1,196 | - | ||||||
Total Fees Paid |
$ | 6,806,760 | $ | 5,440,526 |
Notes:
1. | “Audit Fees” include fees necessary to perform the annual audit or reviews of the consolidated financial statements. |
2. | “Audit-Related Fees” include fees for assurance and related services by the independent auditor that are reasonably related to the performance of statutory audit or review of the Company’s financial statements other than those included in “Audit Fees,” such as consultation on accounting and reporting matters. |
3. | “Tax Fees” include fees for all tax services other than those included in “Audit Fees” and “Audit-Related Fees.” This category includes fees for tax compliance, tax advice and tax planning. |
4. | “Other Fees” include fees for products and services provided by the independent auditor other than those included above, including consulting services. |
The Registrant’s Audit Committee is responsible for pre-approval of all audit services and permitted non-audit services provided to the Registrant or its subsidiaries by Deloitte LLP. The Audit Committee has delegated to the Chair of the Audit Committee, who is independent, the authority to act on behalf of the Audit Committee with respect to the pre-approval of all audit and permitted non-audit services provided by its external auditors from time to time. Any approvals by the Chair are reported to the full Audit Committee at its next meeting. All of the services described in footnotes 2, 3 and 4 under “Principal Accountant Fees and Services” above were approved by the Audit Committee pursuant to paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X.
IDENTIFICATION OF THE AUDIT COMMITTEE
The Registrant has a separately designated standing Audit Committee established in accordance with section 3(a)(58)(A) of the Exchange Act. The members of the Audit Committee are Ernesto M. Hernández, Katherine Kountze, Estelle Métayer, Nicholas Nomicos and Michael Ross.
CORPORATE GOVERNANCE
The Registrant is a “foreign private issuer” as defined in Rule 3b-4 under the Exchange Act and its Subordinate Voting Shares are listed on the Toronto Stock Exchange (“TSX”) and The Nasdaq Global Select Market (“Nasdaq”). Nasdaq Listing Rule 5615(a)(3) permits a foreign private issuer to follow its home country practices in lieu of certain requirements in the Nasdaq Listing Rules. The following is a summary of the significant ways in which the Registrant’s corporate governance practices differ from those required to be followed by U.S. domestic issuers under Nasdaq’s corporate governance standards. In addition, the Registrant is currently a “controlled company” as defined in the Nasdaq Listing Rules. Upon ceasing to be a “controlled company”, as a foreign private issuer, the Registrant intends to continue to follow Canadian corporate governance practices and TSX rules in lieu of the corporate governance requirements of Nasdaq. Except as described below, the Registrant is in compliance with the Nasdaq corporate governance standards in all significant respects.
• | Quorum Requirements. Rule 5620(c) of the Nasdaq Listing Rules requires that the minimum quorum requirement for a meeting of shareholders is 33.33% of the outstanding shares of its common voting stock. In addition, Rule 5620(c) requires that an issuer listed on Nasdaq state its quorum requirement in its by-laws. The Registrant follows the requirements of the Canada Business Corporations Act with respect to quorum requirements. The quorum requirement for a meeting of shareholders is set forth in the Registrant’s by-laws, which require not less than 25% of the issued and outstanding shares entitled to vote at the meeting to be present in person or represented by proxy and at least two persons entitled to vote at the meeting actually present. |
• | Shareholder Approval. Sections 5635(a) through (d) of the Nasdaq Listing Rules require an issuer to obtain shareholder approval prior to certain issuances of securities, including (i) the acquisition of the stock or assets of another company; (ii) equity-based compensation of officers, directors, employees or consultants; (iii) a change of control; and (iv) private placements. The Registrant does not follow this rule. Instead, the Registrant complies with applicable TSX rules. Such rules require issuers to obtain shareholder approval prior to a distribution of common shares (other than in respect of public offerings) that involve the sale of more than 25% of the issuer’s outstanding common shares prior to the transaction. In addition, under TSX rules (1) the creation of, or certain material amendments to, equity compensation plans require shareholder approval and (2) the sale of common shares at a discount to officers and directors requires shareholder approval in specified circumstances. |
• | Compensation Committee. The Registrant follows applicable Canadian laws with respect to compensation consultants, legal counsel and other advisers to our Human Resources & Compensation Committee. Applicable Canadian securities legislation does not specifically require consideration of potential conflicts of interest on the part of compensation consultants, legal counsel and other advisers to the compensation committee, but best practices dictate disclosure of any such conflicts in the Registrant’s management information circular. |
• | Independent Directors. Nasdaq Listing Rule 5605(b) requires that a majority of a listed issuer’s board of directors be independent directors as defined in Nasdaq Listing Rule 5605(a)(2) for companies that are not controlled. Applicable TSX rules require only that listed issuers have at least two independent directors. Although the Registrant is a “controlled company” under Nasdaq rules, we follow applicable TSX requirements with respect to director independence. |
UNDERTAKING AND CONSENT TO SERVICE OF PROCESS
A. Undertaking
Registrant undertakes to make available, in person or by telephone, representatives to respond to inquiries made by the Commission staff, and to furnish promptly, when requested to do so by the Commission staff, information relating to: the securities registered pursuant to Form 40-F, the securities in relation to which the obligation to file an annual report on Form 40-F arises, or transactions in said securities.
B. Consent to Service of Process
The Registrant has previously filed with the SEC an Appointment of Agent for Service of Process and Undertaking on Form F-X in connection with its Subordinate Voting Shares.
SIGNATURE
Pursuant to the requirements of the Exchange Act, the Registrant certifies that it meets all of the requirements for filing on Form 40-F and has duly caused this annual report to be signed on its behalf by the undersigned, thereto duly authorized.
BRP INC. | ||||||||
Date: March 28, 2024 |
By: |
/s/ Sébastien Martel | ||||||
Name |
||||||||
Title: |
Chief Financial Officer |
No. | Document | |
97 |
||
99.1 |
Annual Information Form of the Registrant for the year ended January 31, 2024 | |
99.2 |
||
99.3 |
Management’s discussion and analysis of the Registrant for the year ended January 31, 2024. | |
99.4 |
||
99.5 |
||
23.1 |
||
31.1 |
||
31.2 |
||
32.1 |
||
32.2 |
||
101 |
Inline Interactive Data File. | |
104 |
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
This ‘40-F’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 3/28/24 | 6-K | ||
For Period end: | 1/31/24 | |||
1/31/23 | 40-F | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/18/24 BRP Inc. SUPPL 4/18/24 2:436K Donnelley … Solutions/FA 4/16/24 BRP Inc. SUPPL 4/16/24 1:416K Donnelley … Solutions/FA |